These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6998375)

  • 1. Radiometric prescreen for antitumor activity with Saccharomyces cerevisiae mutant strain.
    Speedie MK; Fique DV; Blomster RN
    Antimicrob Agents Chemother; 1980 Jul; 18(1):171-5. PubMed ID: 6998375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A screening method for antifungal substances using Saccharomyces cerevisiae strains resistant to polyene macrolides.
    Etienne G; Armau E; Tiraby G
    J Antibiot (Tokyo); 1990 Feb; 43(2):199-206. PubMed ID: 2179187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning system.
    Von Hoff DD; Forseth B; Warfel LE
    Cancer Res; 1985 Sep; 45(9):4032-8. PubMed ID: 3928148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast mutants with distorted cell membranes as a detection system for antitumor antibiotics.
    Gause GF; Laiko AV
    Antibiot Chemother (1971); 1978; 23():21-5. PubMed ID: 348079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Utilization of yeast mutants with a defect in the cellular membrane in the search for anticancer antibiotics].
    Gauze GF; Laĭko AV; Selezneva TI
    Antibiotiki; 1976 Jul; 21(7):591-3. PubMed ID: 782350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast sphingolipid bypass mutants as indicators of antifungal agents selectively targeting sphingolipid synthesis.
    Nagiec MM; Young CL; Zaworski PG; Kobayashi SD
    Biochem Biophys Res Commun; 2003 Jul; 307(2):369-74. PubMed ID: 12859966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast mutants with distorted cell membranes as tests in the screening for antitumor antibiotics.
    Gause GF; Laiko AV; Selesneva TI
    Cancer Treat Rep; 1976 May; 60(5):637-8. PubMed ID: 791479
    [No Abstract]   [Full Text] [Related]  

  • 8. A Saccharomyces cerevisiae mutant defines a new locus essential for resistance to the antitumour drug bleomycin.
    Ramotar D; Masson JY
    Can J Microbiol; 1996 Aug; 42(8):835-43. PubMed ID: 8776853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial and nuclear mutagenicity of ellipticine and derivatives in the yeast Saccharomyces cerevisiae.
    Pinto M; Guerineau M; Paoletti C
    Biochem Pharmacol; 1982 Jun; 31(12):2161-7. PubMed ID: 7052092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-based prediction of drug target in yeast.
    Ohnuki S; Okada H; Ohya Y
    Methods Mol Biol; 2015; 1263():319-27. PubMed ID: 25618355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast caspase-dependent apoptosis in Saccharomyces cerevisiae BY4742 induced by antifungal and potential antitumor agent clotrimazole.
    Kavakçıoğlu B; Tarhan L
    Arch Microbiol; 2018 Jan; 200(1):97-106. PubMed ID: 28819786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Screens for Determination of Mechanism of Action.
    Gay-Andrieu F; Alex D; Calderone R
    Methods Mol Biol; 2016; 1356():165-72. PubMed ID: 26519072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.
    Niimi K; Harding DR; Parshot R; King A; Lun DJ; Decottignies A; Niimi M; Lin S; Cannon RD; Goffeau A; Monk BC
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1256-71. PubMed ID: 15047528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.
    Hapala I; Klobucníková V; Mazánová K; Kohút P
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1206-9. PubMed ID: 16246082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved genetically modified Escherichia coli strain for prescreening antineoplastic agents.
    Bartus HR; Mirabelli CK; Auerbach JI; Shatzman AR; Taylor DP; Johnson RK; Rosenberg M; Crooke ST
    Antimicrob Agents Chemother; 1984 May; 25(5):622-5. PubMed ID: 6203484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of morphological alterations by antineoplastic agents in yeast.
    Stavrinidis E; Delitheos A; Tiligada E
    Folia Microbiol (Praha); 2002; 47(2):157-60. PubMed ID: 12058394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defect in dolichol-dependent glycosylation increases sensitivity of Saccharomyces cerevisiae towards anti-fungal drugs.
    Juchimiuk M; Pasikowska M; Zatorska E; Laudy AE; Smoleńska-Sym G; Palamarczyk G
    Yeast; 2010 Aug; 27(8):637-45. PubMed ID: 20602334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae.
    Kontoyiannis DP
    J Antimicrob Chemother; 2000 Aug; 46(2):191-7. PubMed ID: 10933640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of Saccharomyces cerevisiae strains to antineoplastic agents.
    Delitheos A; Karavokyros I; Tiligada E
    J Appl Bacteriol; 1995 Oct; 79(4):379-83. PubMed ID: 7592130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A High-Throughput Yeast Halo Assay for Bioactive Compounds.
    Bray W; Lokey RS
    Cold Spring Harb Protoc; 2016 Sep; 2016(9):. PubMed ID: 27587777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.